This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 October 2023 and includes updates on poliomyelitis, SARS-CoV-2, West Nile virus, the Rugby World Cup 2023, and cryptosporidiosis cases.
In 2021, 1 567 cases of mumps were reported to ECDC by 27 European Union/European Economic Area(EU/EEA) Member States, with an overall notification rate of 0.4 cases per 100 000 population. This wassignificantly lower than the notification rates reported during the previous four years (range 1.7-4.2).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-22 October 2023 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, cryptosporidiosis, dengue, West Nile virus, and mass gathering monitoring for the Rugby World Cup.
This report is based on the findings from two focused After-Action reviews (AARs) in Norway and Georgia that discussed the use of evidence in the advice-making process for long-term care facilities (LTCFs) during the start of the COVID-19 Omicron wave in early 2022.
This handbook provides an overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2 and influenza viruses, provided by the AURORAE consortium.